Status: Recruiting
A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM)
The goal of this clinical trial is to evaluate the safety and efficacy of JL15003 Injection in subjects with recurrent glioblastoma (rGMB).
Participants needed: 40
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Jecho Biopharmaceuticals Co., Ltd.Updated: Mar 30, 2026Locations: 1
Eligibility criteria
1. Age >= 18 years of age; [+9]
1. Subjects who are allergic to any component of the investigational drug, contr... [+28]